BioDelivery Sciences Stock Price

0.14 (3.33%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BioDelivery Sciences International Inc BDSI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.14 3.33% 4.35 08:23:51
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
4.16 4.31 0.15 - -
Trades Volume Avg Volume 52 Week Range
1 200 1,115,550 2.61 - 5.98
Last Trade Time Type Quantity Stock Price Currency
07:50:06 formt 200 $ 4.35 USD

BioDelivery Sciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 439.83M 101.11M 94.95M $ 111.39M $ 15.12M -0.18 28.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 35.33k 4.40%

more financials information »

BioDelivery Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BDSI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.364.464.084.291,181,907-0.01-0.23%
1 Month4.414.994.064.401,258,463-0.06-1.36%
3 Months3.114.993.054.101,024,3411.2439.87%
6 Months4.395.453.044.131,064,340-0.04-0.91%
1 Year5.785.982.614.291,013,142-1.43-24.74%
3 Years2.507.49251.704.38833,1661.8574.0%
5 Years3.857.49251.503.76781,0620.5012.99%

BioDelivery Sciences Description

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, and opioid dependence.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.